Literature DB >> 19472288

Noncompetitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography.

Jianzhong Chen1, John E Schiel, David S Hage.   

Abstract

The peak decay method is an affinity chromatographic technique that has been used to examine the dissociation of solutes from immobilized ligands in the presence of excess displacing agent. However, it can be difficult to find a displacing agent that does not interfere with detection of the eluting analyte. In this study, a noncompetitive peak decay method was developed in which no displacing agent was required for analyte elution. This method was evaluated for the study of drug-protein interactions by using it along with high-performance affinity chromatography to measure the dissociation rate constants for R- and S-warfarin from columns containing immobilized HSA. Several factors were considered in the optimization of this method, including the amount of applied analyte, the column size, and the flow rate. The dissociation rate constants for R- and S-warfarin from HSA were measured at several temperatures by this approach, giving values of 0.56 (+/-0.01) and 0.66 (+/-0.01) s(-1) at pH 7.4 and 37 degrees C. These results were in good agreement with previous values obtained by other methods. This approach is not limited to warfarin and HSA but could be employed in studying additional drug-protein interactions or other systems with weak-to-moderate binding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19472288      PMCID: PMC2773687          DOI: 10.1002/jssc.200900074

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  25 in total

Review 1.  High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-protein binding.

Authors:  D S Hage; J Austin
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-02-28

2.  Determination of drug-plasma protein binding kinetics and equilibria by chromatographic profiling: exemplification of the method using L-tryptophan and albumin.

Authors:  Ann M Talbert; George E Tranter; Elaine Holmes; Peter L Francis
Journal:  Anal Chem       Date:  2002-01-15       Impact factor: 6.986

3.  High-resolution and high-throughput protocols for measuring drug/human serum albumin interactions using BIACORE.

Authors:  R L Rich; Y S Day; T A Morton; D G Myszka
Journal:  Anal Biochem       Date:  2001-09-15       Impact factor: 3.365

4.  Mechanism of binding of warfarin enantiomers to recombinant domains of human albumin.

Authors:  S M Twine; M G Gore; P Morton; B C Fish; A G Lee; J M East
Journal:  Arch Biochem Biophys       Date:  2003-06-01       Impact factor: 4.013

5.  Analysis of small-molecule interactions using Biacore S51 technology.

Authors:  David G Myszka
Journal:  Anal Biochem       Date:  2004-06-15       Impact factor: 3.365

Review 6.  Survey of the year 2003 commercial optical biosensor literature.

Authors:  Rebecca L Rich; David G Myszka
Journal:  J Mol Recognit       Date:  2005 Jan-Feb       Impact factor: 2.137

7.  Further characterization of specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

8.  Interaction of the enantiomers of warfarin with human serum albumin, peptides and amino acids [proceedings].

Authors:  J H Miller; G A Smail
Journal:  J Pharm Pharmacol       Date:  1977-12       Impact factor: 3.765

9.  Stopped-flow studies on drug-protein binding. 1. Kinetics of warfarin binding to human serum albumin.

Authors:  N Rietbrock; A Lassmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

10.  Quantitative uses of affinity chromatography.

Authors:  I M Chaiken
Journal:  Anal Biochem       Date:  1979-08       Impact factor: 3.365

View more
  21 in total

Review 1.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

Review 2.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

3.  Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction.

Authors:  Sandya R Beeram; Xiwei Zheng; Kyungah Suh; David S Hage
Journal:  Methods       Date:  2018-03-03       Impact factor: 3.608

4.  Development of an on-line immunoextraction/entrapment system for protein capture and use in drug binding studies by high-performance affinity chromatography.

Authors:  Elliott L Rodriguez; Saumen Poddar; Meera Choksi; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-11-30       Impact factor: 3.205

5.  High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths.

Authors:  Michelle J Yoo; David S Hage
Journal:  J Sep Sci       Date:  2011-06-10       Impact factor: 3.645

Review 6.  Kinetic analysis of drug-protein interactions by affinity chromatography.

Authors:  Cong Bi; Sandya Beeram; Zhao Li; Xiwei Zheng; David S Hage
Journal:  Drug Discov Today Technol       Date:  2015-10-08

Review 7.  Analytical methods for kinetic studies of biological interactions: A review.

Authors:  Xiwei Zheng; Cong Bi; Zhao Li; Maria Podariu; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2015-01-27       Impact factor: 3.935

8.  Research in bioanalysis and separations at the University of Nebraska - Lincoln.

Authors:  David S Hage; Eric D Dodds; Liangcheng Du; Robert Powers
Journal:  Bioanalysis       Date:  2011-05       Impact factor: 2.681

Review 9.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

10.  CHROMATOGRAPHIC ANALYSIS OF DRUG INTERACTIONS IN THE SERUM PROTEOME.

Authors:  David S Hage; Jeanethe A Anguizola; Abby J Jackson; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; Zenghan Tong; John Vargas-Badilla; Michelle J Yoo; Xiwei Zheng
Journal:  Anal Methods       Date:  2011-07-01       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.